336
[Results] 87 weeks, 36kg, and endpoint was the hard part
STEP. That is the whole post, but I will justify it. Everything else people worry about in c/orforglipron is downstream of it. Titration speed, muscle cramps, the…
u/prior_auth_pain
Four denials, three appeals, one external review, eventually approved. Templates in my posts.
long-standing contributor · appeals · joined 30 Oct 2023
7,733post karma
9,343comment karma
10submissions
160comments
Overview — page 3 of 5
comment on [Results] 87 weeks, 36kg, and endpoint was the hard part in c/trialwatch · 3 points · 2 months ago
press release SURMOUNT posts must be flaired until a publication exists
comment on [Results] 87 weeks, 36kg, and endpoint was the hard part in c/trialwatch · 11 points · 2 months ago
SURMOUNT-4 discontinuation arm showed regain. That is the reality of a chronic disease treatment, not a failure.
comment on [Results] 87 weeks, 36kg, and endpoint was the hard part in c/trialwatch · 13 points · 2 months ago
SURMOUNT-4 discontinuation arm showed regain. That is the reality of a chronic disease treatment, not a failure.
comment on the shortage list question that gets asked weekly, answered properly in c/compounding · 58 points · 3 months ago
Retitled to remove editorialising. Put the evidence in the body.
comment on small win: compounding stopped being a problem at week 40 in c/compounding · 60 points · 3 months ago
no pharmacy referral codes, naming is fine, recruiting is not
comment on help me understand API source, I have read the wiki twice in c/compounding · 52 points · 3 months ago
This is an urgent-care question wearing a forum question's clothes. Please contact a clinician rather than waiting for replies.
comment on packaging: what the trials say vs what this community says in c/coldchain · 0 points · 3 months ago
No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.
comment on telehealth: the version I wish someone had shown me in week 1 in c/compounding · 0 points · 3 months ago
the shortage list is temporary, it ends and compounding becomes illegal again
comment on packaging: what the trials say vs what this community says in c/coldchain · 1 points · 3 months ago
a warm courier van is a bigger problem for a mixed vial than for dry powder
comment on telehealth: the version I wish someone had shown me in week 1 in c/compounding · 13 points · 3 months ago
the Poland situation is different from the US, different regulations
comment on telehealth: the version I wish someone had shown me in week 1 in c/compounding · 24 points · 3 months ago
the the UK situation is different from the US, different regulations
comment on telehealth: the version I wish someone had shown me in week 1 in c/compounding · 14 points · 3 months ago
Flair changed to match the content. Read the sidebar before posting next time and we are square.
318
telehealth: the version I wish someone had shown me in week 1
Week 70 update. 31kg down from the start, muscle cramps basically gone since about week 27. Things that worked: consistency, protein at breakfast, walking more than I…
comment on formulary is the most under-discussed thing in c/coldchain in c/insurancefights · 1 points · 3 months ago
Which plan type? step therapy is different.
comment on switched from 10mg to 7.5mg and the muscle cramps got better, not worse in c/insurancefights · 1 points · 3 months ago
formulary exclusions are negotiable sometimes
comment on [Discussion] the 2.4mg advice in here is 10 years out of date in c/semaglutide · 241 points · 4 months ago
Not convinced. The evidence does not support that reading.
comment on [Discussion] the 503A advice in here is 16 years out of date in c/compounding · 0 points · 4 months ago
state board rules differ, say which state
comment on why does nobody talk about weekly dosing in c/semaglutide · 2 points · 4 months ago
nope, 0.25 counts, it is just not the dose most people stay on
comment on [Meta] the STEP rule is doing its job and people should stop complaining in c/trialwatch · 0 points · 5 months ago
dropout handling matters, especially on GI-heavy populations